March 3, 2026Open Access

A study on the availability of national centralized drug procurement in regions with different levels of economic development: an investigation and analysis of 31 provincial-level administrative regions in China

Key Points

Increased availability of national centralized drug procurement (NCDP) drugs varies across regions, impacting access.
Five batches of NCDP drugs show initial progress, yet disparities remain among economically diverse areas.
Assessment focused on 31 provincial-level regions in China, highlighting the need for optimized supply chains.
Calls for improving policy mechanisms to enhance drug access, addressing inertia in medical behaviours.

Abstract

The implementation of five batches of NCDP drugs has gained initial achievements, but differences persist among regions with varying economic development levels. Accordingly, relevant national departments should optimize the policy implementation mechanism, strengthen the construction of supply chains, and change the inertia of medical behaviour in these regions, aiming to promote the coordinated development of different regions, increase the availability of NCDP drugs and allow people to enjoy policy benefits.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Journals

SHILAP Revista de lepidopterología

Frontiers in Pharmacology

Institutions

Nanjing Drum Tower Hospital

Xuzhou Medical College

Ningxia University

References and Citations

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.